Journal of the Obafemi Awolowo University Medical Student's Association (IFEMED)

Editorial

O Popoola

"A Little Learning is a Dangerous Thing"

Burden of Diabetes Mellitus

O Mojeed, RT Ikem

Editorial article

Pitfalls In Diagnosis And Treatment Of Type 1 Diabetes Mellitus In Childhood

L Lughetti, L Lucaccioni

No Abstract

Appraisal Of Quality Of Life Of Diabetic Patients, Including Life Expectancy

F Popoola, BA Kolawole

Objective: To review the literature on quality of life of diabetic patients, and the impact it has on their life expectancy.
Data Base: Medline, pubmed, google scholar.
Results: Of the several articles yielded by the search, 14 were eventually analyzed. 11 of them were case reports while 3 were original articles. The review showed that patients with diabetes mellitus had signicantly low scores in all four domains of quality of life (physical health, psychological health, social relations, and environment).
Conclusion: Diabetes mellitus has a negative inuence on quality of life, and by extension life expectancy of its sufferers. Current research has shown that there is no signicant difference in the assessment of quality of life regarding gender, age, or the level of education of the patients. Though there are 3 major ways in which diabetes negatively affects well-being, that is the development of long-term complications, development of short-term complications, and physical symptoms and lifestyle changes resulting from the demands of the diabetic regimen, the major determinant of quality of life among diabetic patients was the development of complications with the most common being arterial hypertension, neuropathy, impaired vision, elevated blood lipids and amputation of toes or feet. Future research should therefore focus on how these complications can be prevented, or detected early.

Key words: Type 2 Diabetes, quality of life, life expectancy, diabetic complications.

The Role of Genetics in the Aetiology of Diabetes Mellitus

E Ibukun, O Fasanmade

No Abstract

Diabetic Nephropathy

M Mubaraq, O Oguntola

No Abstract

Diabetic Foot Ulcer

T Agbaje, J Adeleye

No Abstract

Diabetic Eye Disease

DO Deko, OH Onakpoya

No Abstract

Neonatal Diabetes Mellitus

O Ibuola, JBE Busiyan

No Abstract

Hyperosmolar Hyperglycaemic State

FF Adejumo, OF Adesina

No Abstract

The Role Of Lifestyle Modification In The Management Of Diabetes Mellitus

M Aleem, GOD Ajani

No Abstract

Obesity as a Cardiometabolic Risk Factor

AN Ikwu

No Abstract

Surgical Interventions In Diabetes Mellitus

UA Chukwunenye, AO Adisa

ABSTRACT: Diabetes mellitus is a disease caused by deciency or diminished effectiveness of endogenous insulin.

Perioperative Management Of A Diabetic Patient

A Eniola, O Ojo

No Abstract

Recent advances in the Management of Diabetes Mellitus

U Sanusi, BA Kolawole

Diabetes mellitus is a group of common metabolic disorders in which a person has high blood glucose either because the body does not produce enough insulin or because cells do not respond to the insulin. The prevalence of diabetes is rapidly rising all over the globe at an alarming rate. There is an increase in the prevalence of type 1 diabetes also, but the main cause of the diabetic epidemic is type2 diabetes mellitus, which accounts for more than 90 percent of all diabetes cases. Life style modication, oral hypoglycaemic agents, insulin therapy and islet cell transplantation are some of the approaches in the management of diabetes mellitus. Several classes of oral hypoglycemic agents like sulfonylureas, biguanides and alpha-glucosidase inhibitors are available for the treatment of type II diabetes and newer drugs such as GLP-1 mimetic ,DPP-4 inhibitors, SGLT-2 inhibitors, dual peroxisome proliferation activated receptor(PPAR) agonist and G-protein receptor agonist are now available or are being introduced. The goals of this article are to review the current treatments and innovations in the management of diabetes mellitus, highlight the basic pharmacology for new drugs used in diabetes mellitus and discuss the indications and treatment strategies with regards to the newer therapies.

Staphylococcal Scalded Skin Syndrome (SSSS)

O Moninuola, FO Olanrewaju

No Abstract

Diabetic Neuropathy

I Enesi

Diabetes is a chronic metabolic disorder characterized by persistent hyperglycaemia. The prevalence of diabetes is increasing in epidemic proportions worldwide. Diabetic neuropathy is a common clinical complication of Diabetes mellitus, as almost all of diabetic patients will have some form of nerve damage. Majority are asymptomatic, while others show symptoms (depending on the nerve(s) affected) ranging from paraesthesia, numbness to major and fatal neuropathies. Autonomic neuropathies can be prevented by adequate glycaemic control in diabetics. They can be properly managed and their progression considerably slowed down. The type of management instituted will depend on the form of neuropathy.

Diabetic Cystopathy In A Type 2 DM Patient *Omosule

BO Omosule, B Kolawole, FA Owolabi, AA Adelakun

Diabetic cystopathy is a well -recognized but often overlooked complication of diabetes mellitus which usually develops in middle age or at least ten years after the onset of hyperglycemia. In this case report, we present a 48 year old man, diagnosed diabetic ten years before, who presented with painless abdominal swelling and incomplete bladder emptying of a month duration. Random blood glucose at presentation was 30mmol/l. He was managed as a case uncontrolled type 2 Diabetes mellitus with multiple chronic complications amongst which was diabetic cystopathy which prompted him to seek medical intervention. Glycaemic control was achieved with the use of insulin. Initial retention was relieved by passage of a urethral catheter and subsequently timed voiding was emphasized. Good glycaemic control was associated with a signicant improvement in symptoms.

Book Review: Americanah: Through a looking glass glumly

I Ikheola

No Abstract